Top

Published in:

01-10-2014 | Letter to the editor

Motor disability, clinical complications, quality of life, and survival in patients with cancer: a plausible scenario

Authors: Andrea Tendas, Pasquale Niscola, Laura Scaramucci, Marco Giovannini, Teresa Dentamaro, Alessio Pio Perrotti, Paolo de Fabritiis

Published in: Supportive Care in Cancer | Issue 10/2014

Excerpt

To the Editor, …

Chen TY, Janke MC (2014) Predictors of falls among community-dwelling older adults with cancer: results from the health and retirement study. Support Care Cancer 22(2):479–485

Shoda N, Yasunaga H, Horiguchi H, Matsuda S, Ohe K, Kadono Y, Tanaka S (2012) Risk factors affecting inhospital mortality after hip fracture: retrospective analysis using the Japanese Diagnosis Procedure Combination Database. BMJ Open 4:2(3)

Tendas A, Cupelli L, Trawinska MM, Lentini L, Giovannini M, Scaramucci L, Palombi M, Brunetti GA, Cartoni C, de Fabritiis P, Niscola P, Mandelli F (2013) Accidental falls in home care hematological patients. Support Care Cancer 21(8):2087–2089PubMedCrossRef

Tendas A, Cupelli L, Trawinska M, Lentini R, Scaramucci L, Giovannini M, Perrotti A, de Fabritiis P, Niscola P (2013) Disability effect on survival of home care onco-hematological patients. Oral presentation at the 44th Congress of the Italian Society of Hematology (SIE); Oct

Tendas A, Niscola P, Cinque R, Cupelli L, Giovannini M, Ales M, Dentamaro T, Scaramucci L, de Fabritiis P (2010) Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. Leuk Res 34(2):e66PubMedCrossRef

Scaramucci L, Tendas A, Niscola P, Bondanini F, Giovannini M, Palombi M, Cupelli L, Efficace F, Perrotti A, de Fabritiis P (2011) Motor disability in the setting of oral anticoagulant therapy. Int J Hematol 94(5):499–500PubMedCrossRef

Tendas A, Niscola P, Ales M, Baraldi L, Boschetto C, Caiazza E, Cupelli L, Giovannini M, Scaramucci L, Brunetti G, Cartoni C, Mandelli F, de Fabritiis P (2009) Disability and physical rehabilitation in patients with advanced hematological malignancies followed in a home care program. Support Care Cancer 17(12):1559–1560PubMedCrossRef

Tendas A, Cupelli L, Scaramucci L, Palombi M, Trawinska MM, Giovannini M, Brunetti GA, Cartoni C, Bondanini F, de Fabritiis P, Niscola P (2011) Anticoagulant and anti-thrombotic treatments in the management of hematological malignancies in a home care program. Indian J Palliat Care 17(1):54–56PubMedCentralPubMedCrossRef

Niscola P, Cartoni C, Romani C, Brunetti GA, D’Elia GM, Cupelli L, Tendas A, de Fabritiis P, Mandelli F, Foà R (2007) Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey. Ann Hematol 86(9):671–676, Epub 2007 Apr 21PubMedCrossRef

10.

Niscola P, Romani C, Cartoni C, Cupelli L, Piccioni D, Dentamaro T, Tendas A, Giovannini M, Scaramucci L, Tolu B, Perrotti AP, de Fabritiis P (2008) Epidemiology of pain in hospital haematological setting: an Italian survey. Leuk Res 32(1):197–198, Epub 2007 Apr 26PubMedCrossRef

11.

Niscola P, Romani C, Scaramucci L, Dentamaro T, Cupelli L, Tendas A, Piccioni D, Giovannini M, Tolu B, Cartoni C, Arcuri E, Perrotti A, Palumbo R, de Fabritiis P (2008) Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone Marrow Transplant 41(9):757–764PubMedCrossRef

Title: Motor disability, clinical complications, quality of life, and survival in patients with cancer: a plausible scenario
Authors: Andrea Tendas
Pasquale Niscola
Laura Scaramucci
Marco Giovannini
Teresa Dentamaro
Alessio Pio Perrotti
Paolo de Fabritiis
Publication date: 01-10-2014
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 10/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-014-2213-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2014

Predictors of sexual well-being after endometrial cancer: results of a national self-report survey

Validation of the “Quality of Life in Life-Threatening Illness—Family Carer Version” (QOLLTI-F) in German-speaking carers of advanced cancer patients

Bridging cross-cultural gaps: monitoring herbal use during chemotherapy in patients referred to integrative medicine consultation in Israel

Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid

Active treatment given in the last weeks of life: poor quality cancer care or justifiable behavior?

The EAPC framework on palliative sedation and clinical practice—a questionnaire-based survey in Germany

Keynote webinar | Spotlight on antibody–drug conjugates in cancer